Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • FDA

    Tag: fda

    You Searched For "FDA"
    Larotrectinib -first pediatric cancer drug wth 93 % response rate : Lancet

    Larotrectinib -first pediatric cancer drug wth 93 % response rate : Lancet

    Anjali Nimesh Nimesh31 March 2018 7:05 PM IST
    Most cancer drugs are targeted to specific organs or locations in the body. Researchers at UT Southwestern’s Simmons Cancer Center have found ...
    FDA clears first Photochromatic contact lens

    FDA clears first Photochromatic contact lens

    Ruby khatun khatun11 April 2018 7:35 PM IST
    The U.S. Food and Drug Administration has cleared the first F Photochromatic contact lens,a lens with an additive that automatically darkens the lens...
    FDA panel recommends Cannabis derived drug for Epilepsy

    FDA panel recommends Cannabis derived drug for Epilepsy

    Anjali Nimesh Nimesh19 April 2018 7:25 PM IST
    The federal panel recommended the approval of the first prescription cannabidiol medicine which may be used to treat rare and severe forms of...
    Omadacycline - New once daily antibiotic for CABP, Skin Infections

    Omadacycline - New once daily antibiotic for CABP, Skin Infections

    Anjali Nimesh Nimesh22 April 2018 7:31 PM IST
    U.S. Food and Drug Administration (FDA) has accepted the New Drug Applications (NDAs) and granted a priority review for omadacycline, an...
    FDA approves new treatment of Chronic thrombocytopenia ,ITP

    FDA approves new treatment of Chronic thrombocytopenia ,ITP

    Anjali Nimesh Nimesh23 April 2018 7:10 PM IST
    Food and Drug Administration (FDA) has approved Tavalisse (fostamatinib disodium hexahydrate) for the treatment of thrombocytopenia in adults with...
    Praxbind (idarucizumab)-Specific reversal agent for Dabigatran approved

    Praxbind (idarucizumab)-Specific reversal agent for Dabigatran approved

    Medha Baranwal Baranwal24 April 2018 7:05 PM IST
    Praxbind (idarucizumab), the specific reversal agent for Pradaxa (dabigatran etexilate mesylate) received full approval by the U.S. Food and Drug...
    First drug approved for polycystic kidney disease

    First drug approved for polycystic kidney disease

    Vinay Singh singh25 April 2018 7:30 PM IST
    The U.S. Food and Drug Administration has approved the first drug to slow kidney decline in patients with the most common inherited kidney disease....
    FDA approves Trelegy Ellipta for use in COPD

    FDA approves Trelegy Ellipta for use in COPD

    Vinay Singh singh26 April 2018 7:25 PM IST
    US Food and Drug Administration (FDA) has approved an expanded indication for Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol...
    Finally FDA panel confirms that Celecoxib is safe for heart

    Finally FDA panel confirms that Celecoxib is safe for heart

    Medha Baranwal Baranwal28 April 2018 7:20 PM IST
    Cardiovascular (CV) safety of celecoxib, a prescription pain killer, is equivalent to that of naproxen and ibuprofen, concluded two panels of the U.S....
    FDA: Lamotrigine has life threatening side effects

    FDA: Lamotrigine has life threatening side effects

    Anjali Nimesh Nimesh29 April 2018 7:28 PM IST
    Lamotrigine is used alone or with other medicines to treat seizures in patients two years and older.The Food and Drug Administration (FDA) has issued...
    Breakthrough Parkinsonism drug linked to numerous deaths : FDA

    Breakthrough Parkinsonism drug linked to numerous deaths : FDA

    Medha Baranwal Baranwal30 April 2018 7:30 PM IST
    The safety of the Parkinson's drug pimavanserin (Nuplazid) is being reviewed by the U.S. Food and Drug Administration (FDA) following reports of...
    Netarsudil - A new drug for Open-Angle Glaucoma

    Netarsudil - A new drug for Open-Angle Glaucoma

    Vinay Singh singh2 May 2018 7:25 PM IST
    Rhopressa (netarsudil ophthalmic solution) 0.02%, an eye drop indicated for lowering elevated intraocular pressure by upto 5mmHg in patients with...
    PrevNext

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 12 Oct 2022 7:06 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok